PATHO FINAL - ENDOCRINE, NR 507 ENDOCRINE SYSTEM, NR507 MIDTERM, NR 507 FINAL, CNS SENSORY AND MOTOR DISORDERS EXAM WITH COMPLETE SOLUTIONS 2026 LATEST

PATHO FINAL - ENDOCRINE, NR 507 ENDOCRINE SYSTEM, NR507 MIDTERM, NR 507 FINAL, CNS SENSORY AND MOTOR DISORDERS EXAM WITH COMPLETE SOLUTIONS 2026 LATEST
We are a team of academic experts, email us at [email protected] for all Nursing
and Medical academic services, revision exams, testbanks, flashcards, other course
attendance you might need. This is what we do full time. GUARANTEED HIGH GRADES!!
Hypoparathyroidism - CORRECT ANSWER-is an abnormally low PTH level cause by damage or
removal of the parathyroid glands during thyroid surgery. Is also associated with genetic
syndromes (DiGeorge syndrome), autoimmunity and familial disposition. A low magnesium can
also cause a decrease in PTH secretion.
diagnosis of hypoparathyroidism - CORRECT ANSWER-The patient will present with a low serum
calcium level and a high phosphorous level. PTH levels will be low. A serum magnesium and
urinary calcium excretion will help in diagnosing hypoparathyroidism.
treatment of hypoparathyroidism - CORRECT ANSWER-The goal of treatment is to alleviate
hypocalcemia. In an acute state, the patient will receive intravenous calcium to quickly correct
the serum calcium. Maintenance of calcium level is managed through oral calcium and an active
form of vitamin D. PTH replacement therapy with recombinant human parathyroid hormone
(thPTH [1-84]) will help to reduce the need for supplemental calcium and vitamin D. Serum
calcium and phosphate levels will be monitored for return to normal following treatment.
Trousseau sign will result in painful, carpal spasm. - CORRECT ANSWER-true
serum magnesium and urinary calcium excretion will help in diagnosing hypoparathyroidism -
CORRECT ANSWER-true